Cancer Resources

A new vaccine with the possible to heal mesothelioma cancer has been verified protected to use on people today of the asbestos affiliated cancer. According to ScienceDaily, the vaccine functions by infusing “a patient’s personal dendritic cells (DC) with antigen from the patient’s tumor” leading to a response in the patient’s T-cells.

Joachim G Aerts M.D., Ph.D., a pulmonary physician at Erasmus Health care Center in the Netherlands, explains that the vaccine research is the “highly 1st human analyze on DC-dependent immunotherapy in humans with mesothelioma cancer.”

Continue reading ‘Medical Professionals Reveal New Vaccine to Remedy Mesothelioma Discovered Safe And Sound’ »

A vaccine used to prevent cervical cancer in women recently received FDA approval to include the prevention of anal cancer which struck 5,300 men and women in the United States last year, and led to the death of an estimated 720 people.

Gardasil is a vaccine used for the prevention of human papillomavirus (HPV) types 6, 11, 16 and 18. HPV types 16 and 18 cause an estimated 70 to 75 percent of all cervical cancers, and can also lead to the development of anal, vulvar, vaginal and penile cancer. There are more than 200 types of HPV, most of which show no symptoms, and 30 to 40 of them are transmitted sexually, infecting the anal-genital regions.

According to a report by Gardasil maker Merck, “It is estimated that HPV types 16 and 18 account for approximately 80 percent of anal cancers, 75 percent of cervical cancers, 70 percent of vaginal cancers and 40 to 50 percent of vulvar cancers.” Ninety-percent of all genital wart cases are traced to types 6 and 11. Continue reading ‘FDA Approves Gardasil for Prevention of Anal Cancer’ »

Incoming search terms:

• Merck Gardasil Patent expiration
• when does the patent on gardasil expire

A vaccine which was originally developed to combat the herpes virus attacks cancerous tumors causing skin cancer, a therapy helping patients to fully cure from melanoma, according to some American researchers, even at an advanced stage.

What has really surprised and encouraged us was to see that this vaccine Onco VEX did not addressed only to cells that were injected, but worked on cells in other parts of the body that we could not reach, said Dr. Howard Kaufman from the Rush University Medical Center in Chicago. In other words, the vaccine triggered an immune response that spreads throughout the body thanks to the bloodstream. Mr. Kaufman is now well prepared to launch a Phase III clinical trials, which will involved 430 patients across the United States. During Phase II, fifty patients with melanoma at the stage of metastasis have been vaccinated. Eight of them have fully recovered and four partially responded positively to the treatment. Continue reading ‘Finally a Cure For Skin Cancer’ »

Incoming search terms:

• any good results with oncovex

Cancer these days are so common that there is a 50 to 75 per cent chance that someone in you family could be diagnosed with it. Cancer takes many forms and to date, there is no known cure that can completely eliminate this disease.

The Human Papillomavirus (HPV) is a virus that causes different types of cancers. The HPV 16 and HPV 18 cause cervical and vulval cancer. A recent study by a leading Cancer Research scientific team found a vaccine to combat against certain forms of the Human Papilomavirus.

The vaccine, known as TA-HPV was modified from a smallpox vaccine. Scientists tested the vaccine in 18 women with Vulval Intraepithelial Neoplasia (VIN), a form of vulval cancer. This form of vulval cancer is very hard to treat as the precancerous lesions appear on the lining of the vulva. Continue reading ‘Is There A Vaccine For Cancer?’ »